Hazlett, Burt & Watson’s Eli Lilly LLY Stock Holding History

Hazlett, Burt & Watson’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.08M	Buy	2,569 +143	+6%	+$146K	0.82%	27
2026 Q1	$2.24M	Buy	2,426 +53	+2%	+$53.7K	0.7%	32
2025 Q4	$2.55M	Buy	2,373 +271	+13%	+$259K	0.81%	24
2025 Q3	$1.61M	Buy	2,102 +262	+14%	+$195K	0.57%	41
2025 Q2	$1.43M	Buy	1,840 +316	+21%	+$246K	0.59%	42
2025 Q1	$1.26M	Buy	1,524 +26	+2%	+$21.6K	0.57%	46
2024 Q4	$1.16M	Buy	1,498 +40	+3%	+$33.1K	0.51%	47
2024 Q3	$1.29M	Buy	1,458 +109	+8%	+$98K	0.59%	36
2024 Q2	$1.23M	Buy	1,349 +58	+4%	+$46.4K	0.63%	34
2024 Q1	$1M	Buy	1,291 +85	+7%	+$60.5K	0.6%	34
2023 Q4	$703K	Buy	1,206 +427	+55%	+$249K	0.47%	44
2023 Q3	$419K	Buy	779 +159	+26%	+$81.9K	0.31%	67
2023 Q2	$290K	Buy	620 +269	+77%	+$113K	0.22%	96
2023 Q1	$121K	Buy	351 +21	+6%	+$7.08K	0.1%	175
2022 Q4	$121K	Buy	330 +1	+0.3%	+$355	0.11%	168
2022 Q3	$107K	Hold	329	–	–	0.1%	172
2022 Q2	$107K	Buy	329 +1	+0.3%	+$300	0.1%	189
2022 Q1	$94K	Buy	+328	New	+$84.4K	0.07%	217

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hazlett, Burt & Watson's LLY Position: Q2 2026 in Review

Hazlett, Burt & Watson increased its Eli Lilly (LLY) stake by 5.9% in Q2 2026, buying an estimated $146K and bringing the position to 2,569 shares worth $3.08M. The position accounts for 0.82% of the portfolio, ranked #27.

Hazlett, Burt & Watson first reported a position in LLY in Q1 2022 and has held it in 18 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Hazlett, Burt & Watson held 2,569 shares of Eli Lilly worth $3.08M as of Q2 2026.
Hazlett, Burt & Watson bought 143 Eli Lilly shares in Q2 2026, an estimated $146K.
Eli Lilly made up 0.82% of Hazlett, Burt & Watson's portfolio in Q2 2026, its #27 holding.
Hazlett, Burt & Watson first reported a position in Eli Lilly in Q1 2022 and has held it in 18 quarters since.
4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.